Walker R F, Codd E E
J Neuroimmunol. 1985 Nov;10(1):41-58. doi: 10.1016/0165-5728(85)90033-5.
Monoamine neuroleptics alter rodents responses to immunization, suggesting that norepinephrine (NE) and serotonin (5HT) are neuroimmunomodulatory in these animals. Although endocrine factors participate in their mechanism(s) of action, recent studies suggest that NE and 5HT also interact more directly with immunocompetent cells. This review provides an overview of evidence for a direct regulatory link between the nervous and immune systems and further speculates on the process by which NE and 5HT realize in part, their neuroimmunomodulatory potential. Anatomical data show that noradrenergic fibers of the sympathetic nervous system innervate lymphoid organs providing a channel of communication between neurons and lymphocytes. Presumably neural signals transmitted by NE are received by platelets that in turn, transduce them via 5HT into immunomodulatory messages. It is proposed that NE alters the capacity of platelets to sequester and/or catabolize 5HT, thus regulating its physiologically active pool in the plasma. Macrophages possess a 5HT uptake system, the kinetic properties of which make them sensitive to changes in plasma levels of the amine. Thus, through its ability to regulate plasma levels of 5HT, an immunosuppressive amine with access to macrophages, the nervous system can influence cells involved in antigen recognition. Support for this hypothetical immunomodulatory mechanism is gleaned from clinical and experimental studies. For example, individuals suffering emotional trauma are more susceptible than others to developing physical illness. It is of interest that platelet 5HT pharmacodynamics are often abnormal in patients with psychological disorders characterized by catecholamine deficits. Similar platelet changes have been achieved experimentally by treating rats with catecholamine antimetabolites. Additional support for the hypothesis derives from aging research since 'monoamine imbalance' and immune dysfunction are co-characteristics of senescence. In aging rodents and humans, central catecholamine deficits are associated with a decreased platelet affinity for 5HT and an increased plasma content of 5HT. Thus, emotional, spontaneous (age-related), or experimental changes in monoamine homeostasis have the potential to increase the risk of disease in affected individuals. Perhaps part of this effect results from endocrine perturbations associated with the trauma. However, a direct interaction between the nervous and immune systems involving monoamines is also possible, and a need for future study of this potentially significant mechanism for neuroimmunomodulation is indicated.
单胺类神经阻滞剂会改变啮齿动物对免疫的反应,这表明去甲肾上腺素(NE)和血清素(5-羟色胺,5HT)在这些动物中具有神经免疫调节作用。尽管内分泌因素参与了它们的作用机制,但最近的研究表明,NE和5HT也能更直接地与免疫活性细胞相互作用。这篇综述概述了神经系统和免疫系统之间存在直接调节联系的证据,并进一步推测了NE和5HT部分实现其神经免疫调节潜能的过程。解剖学数据显示,交感神经系统的去甲肾上腺素能纤维支配着淋巴器官,为神经元和淋巴细胞之间提供了一条通讯通道。据推测,由NE传递的神经信号被血小板接收,血小板继而通过5HT将这些信号转导为免疫调节信息。有人提出,NE会改变血小板隔离和/或分解代谢5HT的能力,从而调节其在血浆中的生理活性库。巨噬细胞拥有一个5HT摄取系统,其动力学特性使其对胺类血浆水平的变化敏感。因此,通过调节5HT的血浆水平,神经系统能够影响参与抗原识别的细胞,5HT是一种能作用于巨噬细胞的免疫抑制性胺。对这一假设的免疫调节机制的支持来自临床和实验研究。例如,遭受情感创伤的个体比其他人更容易患上身体疾病。有趣的是,在以儿茶酚胺缺乏为特征的心理障碍患者中,血小板5HT的药效学往往异常。通过用儿茶酚胺抗代谢物治疗大鼠,实验中也观察到了类似的血小板变化。对这一假设的进一步支持来自衰老研究,因为“单胺失衡”和免疫功能障碍是衰老的共同特征。在衰老的啮齿动物和人类中,中枢儿茶酚胺缺乏与血小板对5HT的亲和力降低以及血浆中5HT含量增加有关。因此,单胺稳态的情绪性、自发性(与年龄相关)或实验性变化有可能增加受影响个体患疾病的风险。这种影响可能部分是由与创伤相关的内分泌紊乱导致的。然而,神经系统和免疫系统之间涉及单胺的直接相互作用也是可能的,这表明未来需要对这种潜在的重要神经免疫调节机制进行研究。